INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 38 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $48,000 | -66.2% | 65,649 | +101.3% | 0.00% | -69.2% |
| Q2 2019 | $142,000 | -69.6% | 32,609 | -48.8% | 0.01% | -71.1% |
| Q1 2019 | $467,000 | -15.9% | 63,692 | -13.5% | 0.04% | -44.4% |
| Q4 2018 | $555,000 | +228.4% | 73,669 | +146.3% | 0.08% | +376.5% |
| Q3 2018 | $169,000 | +53.6% | 29,905 | +19.7% | 0.02% | +70.0% |
| Q2 2018 | $110,000 | – | 24,982 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,724,283 | $17,231,000 | 2.81% |
| Avoro Capital Advisors LLC | 2,195,705 | $13,943,000 | 0.67% |
| MEITAV INVESTMENT HOUSE LTD | 1,605,940 | $10,156,000 | 0.52% |
| CAXTON CORP | 64,280 | $395,000 | 0.43% |
| Cormorant Asset Management, LP | 773,816 | $4,894,000 | 0.36% |
| SECTORAL ASSET MANAGEMENT INC | 451,252 | $2,854,000 | 0.31% |
| Anson Funds Management LP | 50,000 | $316,000 | 0.24% |
| Migdal Insurance & Financial Holdings Ltd. | 522,067 | $3,302,000 | 0.08% |
| MENTA CAPITAL LLC | 26,959 | $171,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,725,000 | $10,911,000 | 0.02% |